Marshwinds Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Marshwinds Advisory's LLY Position: Q4 2018 in Review
Marshwinds Advisory reduced its Eli Lilly (LLY) stake by 1.6% in Q4 2018, selling an estimated $72.5K and leaving 39,030 shares worth $4.52M. The position accounts for 2.42% of the portfolio, ranked #6.
Marshwinds Advisory first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. 1,561 funds tracked by Wall St. Rank hold LLY as of Q4 2018.
- Marshwinds Advisory held 39,030 shares of Eli Lilly worth $4.52M as of Q4 2018.
- Marshwinds Advisory sold 649 Eli Lilly shares in Q4 2018, an estimated $72.5K.
- Eli Lilly made up 2.42% of Marshwinds Advisory's portfolio in Q4 2018, its #6 holding.
- Marshwinds Advisory first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
- 1,561 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.
Based on Marshwinds Advisory's 13F filing for Q4 2018, filed 7 Jan 2019.